Radiological and histological correlation according to BI-RADS system: positive predictive value of categories 3, 4 and 5
Keywords:
predictive value of tests, mammography, breast neoplasms.Abstract
ABSTRACTObjective: to analyze studies comparing mammographic findings according to BI-RADS, with histology, evaluating the positive predictive value of categories 3, 4 and 5. Materials and Methods: a review was conducted of Medline - Pubmed e SciELO - Lilacs, using the terms: “predictive value” and “BI-RADS or BIRADS” and “mammography”. Fifteen articles were included in this review, with the following criteria: original articles evaluating the positive predictive value (PPV) of categories 3, 4 and 5, based on the histopathological results of at least 100 injuries, work published since 1998; Articles in Portuguese, English or Spanish. Results: the positive predictive value of categories 3, 4 and 5 ranges between 0% and 8%, 4% and 67,8%, 54% and 100%, respectively. It was found that the lesions of greatest risk for malignant masses are speculated margin, high density and irregular shape and branching calcifications described as thin, linear or segmental distribution. We also found that the most common cancer in the calcified lesions were ductal carcinoma in situ and in the others lesions were infiltrating ductal carcinoma. Conclusion: the classification of BI-RADS system is useful and valuable to predict the presence of malignancy, allowing to discriminate, with some security, patients with higher risk of breast cancer. To reduce the performance of unnecessary invasive procedures, we suggest that the lesions are also analyzed according to morphological criteria.
Downloads
References
Brasil. Ministério da Saúde. Instituto Nacional de Câncer. Estimativa 2006: incidência de câncer no Brasil [Internet]. 2006 [acesso em 15 maio 2011]. Disponível em: http://www1.inca.gov.br/estimativa/2006/.
National Cancer Institute. Surveillance Epidemiology and End Results (SEER) [Internet]. [acesso em 15 maio 2011]. Disponível em: http://seer.cancer.gov.
Brasil. Ministério da Saúde. Instituto Nacional de Câncer. Estimativa 2010: incidência de câncer no Brasil [Internet]. 2010[acesso 15 maio 2011]. Disponível em: http://www1.inca.gov.br/estimativa/2010/.
Newman LA, Sabel M. Advances in breast cancer detection and management. Med Clin North Am. 2003;87:997-1028.
Bellantone R, Rossi S, Lombardi CP, De Fazio S, Agresti M, Pastore G, et al. [Nonpalpable lesions of the breast. Diagnostic and therapeutic considerations]. Minerva Chir. 1994;49:327-33.
Thuler LC. Considerações sobre a prevenção do câncer de mama feminino. Rev Bras Cancerol. 2003;49:227-38.
Ciatto S, Cataliotti L, Distante V. Nonpalpable lesions detected with mammography: review of 512 consecutive cases. Radiology. 1987;165:99-102.
Cyrlak D. Induced costs of low-cost screening mammography. Radiology. 1988;168:661-3.
Hall FM, Storella JM, Siverstone DZ, Wyshak G. Nonpalpable breast lesions: recommendation for biopsy based on suspicion of carcinoma at mammography. Radiology. 1988;167:353-8.
American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS). Reston: American College of Radiology; 1993.
American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS). 2nd ed. Reston: American College of Radiology; 1995.
American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS®). 3rd ed. Reston: American College of Radiology; 1998.
American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS®). 4th ed. Reston: American College of Radiology; 2003.
Chala LF, Barros N. ACR BI-RADS™ na ultrasonografia. Radiol Bras. 2004;37:III–IV.
Camargo Júnior HSA. BI-RADS®-ultra-som: vantagens e desvantagens dessa nova ferramenta de trabalho. Radiol Bras. 2005;38:301-3.
Liberman L, Menell JH. Breast Imaging Reporting and Data System (BI-RADS). Radiol Clin North Am. 2002;40:409-30.
Orel SG, Kay N, Reynolds C, Sullivan DC. BIRADS categorization as a predictor of malignancy. Radiology. 1999;211:845-50.
Ball CG, Butchart M, MacFarlane JK. Effect on biopsy technique of the breast imaging reporting and data system (BI-RADS) for nonpalpable mammographic abnormalities. Can J Surg. 2002;45:259-63.
Melhado VC, Alvares BR, Almeida OJ. Correlação radiológica e histológica de lesões mamárias não palpáveis em pacientes submetidas a marcação pré cirúrgica, utilizando-se o sistema BI-RADS®. Radiol Bras. 2007;40:9-11.
Resende LMP, Matias MA, Oliveira GM, Salles MA, Melo FH, Gobbi H. Avaliação de microcalcificações mamárias de acordo com as classificações do Breast Imaging Reporting and Data System e de Le Gal. Rev Bras Ginecol Obstet. 2008;30:75-9.
Prado GLM, Guerra MT. Valor preditivo positivo das categorias 3, 4 e 5 do Breast Imaging Reporting and Data System (BI-RADS). Radiol Bras. 2010;43:171-4.
Margolin FR, Leung JW, Jacobs RP, Denny SR. Percutaneous imaging-guided core breast biopsy: 5 years' experience in a community hospital. AJR Am J Roentgenol. 2001;177:559-64.
Tate PS, Rogers EL, McGee EM, Page GV, Hopkins SF, Shearer RG, et al. Stereotactic breast biopsy: a six-year surgical experience. J Ky Med Assoc. 2001;99:98-103.
Mendez A, Cabanillas F, Echenique M, Malekshamran K, Perez I, Ramos E. Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB). Ann Oncol. 2004;15:450-4.
Tan YY, Wee SB, Tan MP, Chong BK. Positive predictive value of BI-RADS categorization in an Asian population. Asian J Surg. 2004;27:186-91.
Zonderland HM, Pope TL Jr, Nieborg AJ. The positive predictive value of the Breast Imaging Reporting and Data System (BI-RADS) as a method of quality assessment in breast imaging in a hospital population. Eur Radiol. 2004;14:1743-50.
Muller-Schimpfle M, Wersebe A, Xydeas T, Fishman A, Vogel U, Fersis N, et al. Microcalcifications of breast. How does radiologic classification correlate with histology? Acta Radiol. 2005;46:774-81.
Kim EK, Ko KH, Oh KK, Kwak JY, You JK, Kim MJ, and Park BW. Clinical application of the BI-RADS final assessment to breast sonography in conjunction with mammography. Am J Roentgenol. 2008;190:1209-15.
Bent CK, Bassett LW, D'Orsi CJ, Sayre JW. The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories. AJR Am J Roentgenol. 2010;194:1378-83.
Bérubé M, Curpen B, Ugolini P, Lalonde L, Ouimet- Oliva D. Level of suspicion of a mammographic lesion: use of features defined by BIRADS lexicon and correlation with large-core breast biopsy. Can Assoc Radiol J. 1998;49:223-8.
Shapiro S. Determining the efficacy of breast cancer screening. Cancer. 1989;63:1873-80.
Dodd GD. American Cancer Society guidelines on screening for breast cancer. An overview. Cancer. 1992;69:1885-7.
Hurley SF, Kaldor JM. The benefits and risks of mammographic screening for breast cancer. Epidemiol Rev. 1992;14:101-30.
Smart CR, Hartmann WH, Beahrs OH, Garfinkel L. Insights into breast cancer screening of younger women. Evidence from the 14-year follow-up of the Breast Cancer Detection Demonstration Project. Cancer. 1993;72:1449-56.
Nystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Rydén S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993;341:973-8.
Smart CR. Highlights of the evidence of benefit for women aged 40-49 years from the 14-year follow-up of the Breast Cancer Detection Demonstration Project. Cancer. 1994;74:296-300.
Nascimento JHR, Silva VD, Maciel AC. Acurácia dos achados mamográficos do câncer de mama: correlação da classificação BI-RADS® e achados histológicos. Radiol Bras. 2010;43:91-6.
Klautau-Leite AP, Nicola H, Scaciota AP, Milani V, Souza LR, Uemura L. Valor do BI-RADS ultrassonográfico na distinção entre lesões malignas e benignas: estudo da variação interobservador e correlação com anátomo-patológico. Rev Imagem. 2004;142:33-9.
Vianna AD, Marchiori E, Vianna AS, Vianna PE. Calcificações arredondadas como único achado mamográfico no carcinoma da mama: correlação mamografia-anatomia patológica. Radiol Bras. 2004;38:163-7.
Downloads
Published
How to Cite
Issue
Section
License
Os autores no momento da submissão transferem os direitos autorais, assim, os manuscritos publicados passam a ser propriedade da revista.
O conteúdo do periódico está licenciado sob uma Licença Creative Commons 4.0, esta licença permite o livre acesso imediato ao trabalho e que qualquer usuário leia, baixe, copie, distribua, imprima, pesquise ou vincule aos textos completos dos artigos, rastreando-os para indexação, passá-los como dados para o software, ou usá-los para qualquer outra finalidade legal.